The Association of Relaxin and CD40 with Glycemic and Inflammatory Markers in Patients with Atherosclerosis

Authors

  • zahraa Al-yasiri كلية العلوم -جامعة الكوفة

DOI:

https://doi.org/10.36320/ajb/v17.i3.20299

Keywords:

Atherosclerosis, CD40, Relaxin, Inflammation, Endothelial dysfunction, Lipid profile, Biomarkers, ROC curve, Immune response

Abstract

Background & Objective: Atherosclerosis is a long-term inflammatory condition that causes plaque to gradually build up in artery walls. It frequently results in ischemic problems and vascular blockage. Vascular remodeling signals and immune-inflammatory mediators are important factors in the development of illness. The purpose of this study was to examine the pathological and diagnostic importance of CD40 and Relaxin levels in atherosclerosis patients as well as their relationships to hematological markers and lipid profiles.

Methods: 90 individuals aged 45 to 65 were divided into three groups for a case-control study: thirty patients with atherosclerosis who also had diabetes and hypertension, thirty pathological controls who had both diseases but no atherosclerosis, and thirty healthy controls. Blood samples obtained while fasting were analyzed for lipid profiles, hematological traits, and inflammatory markers (Relaxin , CD40). ELISA and spectrophotometric techniques were applied. Statistical analysis was done using SPSS v26.

Results: According to the study, CD40 and Relaxin levels were noticeably higher in atherosclerosis patients (P = 0.001). The strong correlation between CD40 and lymphocyte count (r = 0.421, P = 0.046) lends credence to CD40's function in immune-system-induced vascular inflammation . There was a positive connection between VLDL and relaxin levels (r = 0.464, P = 0.026), suggesting a metabolic-compensatory relationship. Furthermore, the patient group's hematological markers (WBCs, PLT, and LYM) were significantly higher. According to ROC analysis, Relaxin performed somewhat well in terms of diagnostic accuracy (AUC = 0.758), whereas CD40 had outstanding diagnostic accuracy (AUC = 0.880, sensitivity = 87%, specificity = 80%).

 

Downloads

Download data is not yet available.

References

1. Libby, P. (2021). The changing landscape of atherosclerosis. Nature, 592(7855), 524-533.‏ DOI: https://doi.org/10.1038/s41586-021-03392-8

2. Ali, B., & Mohammed, U. J. (2024). The association of atherosclerosis with cortisol and alpha-enolase levels and lipid profile. Anaesthesia, Pain & Intensive Care, 28(6), 1097-1104.‏

3. Ngema, M., Xulu, N. D., Ngubane, P. S., & Khathi, A. (2024). A Review of Fetal Development in Pregnancies with Maternal Type 2 Diabetes Mellitus (T2DM)-Associated Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysregulation: Possible Links to Pregestational Prediabetes. Biomedicines, 12(6), 1372.‏ DOI: https://doi.org/10.3390/biomedicines12061372

4. Wilhelmi, T. P. (2023). Evaluation of the antifibrotic potential of Serelaxin in two experimental models of cardiac fibrogenesis.‏

5. Huang, W. C., Chuang, C. F., Huang, Y. T., Chung, I. C., Chen, M. L., Chuang, T. Y., ... & Yuan, T. T. (2023). Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis. Respiratory research, 24(1), 280.‏ DOI: https://doi.org/10.1186/s12931-023-02583-3

6. Kalafateli, M., Aggeletopoulou, I., & Triantos, C. (2024). Adrenal insufficiency in liver diseases-pathophysiology and underlying mechanisms. Reviews in Endocrine and Metabolic Disorders, 25(4), 663-676.‏ DOI: https://doi.org/10.1007/s11154-024-09874-0

7. Ali, B. M., Moein, F., Al-Andaleb, M., Hussein, Z., Abidali, M. K., & Dhyaa, S. (2021). STUDY OF SOME FACTORS AFFECTING IN MYOCARDIAL INFARCTION. Annals of the Romanian Society for Cell Biology, 25(6).‏

8. Ali, B. M., Moein, F., Al-Andaleb, M., Hussein, Z., Abidali, M. K., & Dhyaa, S. (2021). STUDY OF SOME FACTORS AFFECTING IN MYOCARDIAL INFARCTION. Annals of the Romanian Society for Cell Biology, 25(6).‏

9. Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023). Insulin resistance and cardiovascular disease. Journal of International Medical Research, 51(3), 03000605231164548.‏ DOI: https://doi.org/10.1177/03000605231164548

10. Risan, T. Z., & Ali, B. M. (2024, March). Study the effect of amphetamine on neurotransmitter factors in abusers individuals. In AIP Conference Proceedings (Vol. 3092, No. 1). AIP Publishing.‏

11. Vekic, J., Zeljkovic, A., Cicero, A. F., Janez, A., Stoian, A. P., Sonmez, A., & Rizzo, M. (2022). Atherosclerosis development and progression: the role of atherogenic small, dense LDL. Medicina, 58(2), 299.‏ DOI: https://doi.org/10.3390/medicina58020299

12. Bekbossynova, M., Saliev, T., Ivanova-Razumova, T., Andossova, S., Kali, A., & Myrzakhmetova, G. (2025). Beyond Cholesterol: Emerging Risk Factors in Atherosclerosis. Journal of Clinical Medicine, 14(7), 2352.‏ DOI: https://doi.org/10.3390/jcm14072352

13. Pacinella, G., Ciaccio, A. M., & Tuttolomondo, A. (2024). Molecular Links and Clinical Effects of Inflammation and Metabolic Background on Ischemic Stroke: An Update Review. Journal of Clinical Medicine, 13(24), 7515.‏ DOI: https://doi.org/10.3390/jcm13247515

14. Dakal, T. C., Xiao, F., Bhusal, C. K., Sabapathy, P. C., Segal, R., Chen, J., & Bai, X. (2025). Lipids dysregulation in diseases: core concepts, targets and treatment strategies. Lipids in Health and Disease, 24(1), 61.‏ DOI: https://doi.org/10.1186/s12944-024-02425-1

15. Ali, B., & Mohammed, U. J. (2024). The association of atherosclerosis with cortisol and alpha-enolase levels and lipid profile. Anaesthesia, Pain & Intensive Care, 28(6), 1097-1104.‏

16. Almohanna, T., Auda, F. M., & Ali, B. M. (2025). Early Detection of Digestive System Cancers: Insights from Enzymatic and Non-Enzymatic Tumor Markers. Journal of Medical Biochemistry, 44(3), 631-636.‏ DOI: https://doi.org/10.5937/jomb0-56390

17. Risan, T. Z., & Ali, B. M. (2024, March). Study the effect of amphetamine on neurotransmitter factors in abusers individuals. In AIP Conference Proceedings (Vol. 3092, No. 1). AIP Publishing DOI: https://doi.org/10.1063/5.0200213

18. Strohm, L., Daiber, A., Ubbens, H., Krishnankutty, R., Oelze, M., Kuntic, M., ... & Daub, S. (2024). Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies. Basic Research in Cardiology, 119(4), 1-18.‏ DOI: https://doi.org/10.1007/s00395-024-01045-1

19. Pintalhão, M. M. S. (2024). New Insights Into Circulating Biomarkers in Heart Failure: Unravelling the Role of Relaxin and Urocortin-2 (Doctoral dissertation, Universidade do Porto (Portugal)).‏

20. Auda, F. M., Ali, B. M., Al-Andaleb, M., Abidali, M. K., & Dhyaa, S. (2021). Estimation of Hepcidin and Sexual Hormones Levels in Patients with Atherosclerosis in Al-Najaf City/Iraq. Indian Journal of Forensic Medicine & Toxicology, 15(3), 5235-5239.‏ DOI: https://doi.org/10.37506/ijfmt.v15i3.16264

21. Tian, S., Wang, Y., Wan, J., Yang, M., & Fu, Z. (2024). Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: a review. Medicine, 103(14), e37718.‏ DOI: https://doi.org/10.1097/MD.0000000000037718

22. Gissler, M. C., Scherrer, P., Anto-Michel, N., Pennig, J., Hoppe, N., Füner, L., ... & Willecke, F. (2021). Deficiency of endothelial CD40 induces a stable plaque phenotype and limits inflammatory cell recruitment to atherosclerotic lesions in mice. Thrombosis and Haemostasis, 121(11), 1530-1540.‏ DOI: https://doi.org/10.1055/a-1397-1858

23. Ali, B. M., Alassadi, P., Iqbal, J., & Zearah, A. P. (2020). Study the effect of antioxidants and oxidative products and their genetic effect on methionine synthase in people with autism spectrum disorder. Proff. Sameerah Ahmed, Study the Effect of Antioxidants and Oxidative Products and Their Genetic Effect on Methionine Synthase in People with Autism Spectrum Disorder (March 23, 2020). DOI: https://doi.org/10.2139/ssrn.3559385

24. Tudurachi, B. S., Anghel, L., Tudurachi, A., Sascău, R. A., & Stătescu, C. (2023). Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte/HDL–cholesterol ratio) in acute myocardial infarction and particularities in young patients. International journal of molecular sciences, 24(18), 14378.‏ DOI: https://doi.org/10.3390/ijms241814378

25. Bańka, P., Męcka, K., Berger-Kucza, A., Wrona-Kolasa, K., Rybicka-Musialik, A., Nowak, B., ... & Mizia-Stec, K. (2025). Biomarkers of Calcification, Endothelial Injury, and Platelet-Endothelial Interaction in Patients with Aortic Valve Stenosis. International Journal of Molecular Sciences, 26(10), 4873.‏ DOI: https://doi.org/10.3390/ijms26104873

26. Priyambda, K., Swarnakar, M., & Chandrakar, R. K. (2024). Hematologic Indices as Diagnostic Markers in Acute Coronary Syndrome: Unraveling their Significance. Int J Life Sci Biotechnol Pharma Res, 13(4), 157-163.‏

27. Bai, J., & Zhou, H. (2025). Relaxin‐2 mitigates the interaction between monocytes and endothelial cells by suppressing Egr‐1. Fundamental & Clinical Pharmacology, 39(3).‏ DOI: https://doi.org/10.1111/fcp.70007

28. Hajishengallis, G., Netea, M. G., & Chavakis, T. (2025). Trained immunity in chronic inflammatory diseases and cancer. Nature Reviews Immunology, 1-18.‏

29. Hajishengallis, G., Netea, M. G., & Chavakis, T. (2025). Trained immunity in chronic inflammatory diseases and cancer. Nature Reviews Immunology, 1-18.‏ DOI: https://doi.org/10.1038/s41577-025-01132-x

30. Mohanta, S. K., Heron, C., Klaus-Bergmann, A., Horstmann, H., Brakenhielm, E., Giannarelli, C., ... & Weber, C. (2025). Metabolic and immune crosstalk in cardiovascular disease. Circulation Research, 136(11), 1433-1453.‏ DOI: https://doi.org/10.1161/CIRCRESAHA.125.325496

31. Benallegue, N., Kebir, H., & Alvarez, J. I. (2022). Neuroinflammation: extinguishing a blaze of T cells. Immunological reviews, 311(1), 151-176.‏ DOI: https://doi.org/10.1111/imr.13122

32. Ali, B., & Mohammed, U. J. (2024). The association of atherosclerosis with cortisol and alpha-enolase levels and lipid profile. Anaesthesia, Pain & Intensive Care, 28(6), 1097-1104.‏ DOI: https://doi.org/10.35975/apic.v28i6.2609

33. Guimarães, J., de Almeida, J., Mendes, P. L., Ferreira, M. J., & Gonçalves, L. (2024). Advancements in non-invasive imaging of atherosclerosis: Future perspectives. Journal of Clinical Lipidology, 18(2), e142-e152.‏ DOI: https://doi.org/10.1016/j.jacl.2023.11.008

34. Wróbel-Nowicka, K., Wojciechowska, C., Jacheć, W., Zalewska, M., & Romuk, E. (2024). The role of oxidative stress and inflammatory parameters in heart failure. Medicina, 60(5), 760.‏ DOI: https://doi.org/10.3390/medicina60050760

Downloads

Published

2025-12-01

How to Cite

Al-yasiri, zahraa. (2025). The Association of Relaxin and CD40 with Glycemic and Inflammatory Markers in Patients with Atherosclerosis. Al-Kufa University Journal for Biology, 17(3), 39-48. https://doi.org/10.36320/ajb/v17.i3.20299

Share